CD209 and cancer: Moreover, it was demonstrated that semen clusterin is not only a promising ligand for DC-SIGN in cancer, it also abolishes the binding of HIV-1 to DC-SIGN by high-affinity binding fucose-rich glycans on semen clusterin to DC-SIGN [74].